Abbott Laboratories Stock Kazakhstan S.E.
Stocks
ABT_KZ
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
02:00:09 08/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 98.93 USD | -10.06% |
|
+4.76% | -23.61% |
| 08:14pm | Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target | MT |
| 10-06 | Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities | CI |
| Market Cap | 170B 152B 142B 129B 242B 16,431B 244B 1,701B 665B 8,356B 638B 624B 26,863B | P/E 2026 * |
28.7x | P/E 2027 * | 22.3x |
|---|---|---|---|---|---|
| Enterprise Value | 194B 173B 162B 147B 276B 18,747B 278B 1,941B 758B 9,534B 728B 712B 30,649B | EV / Sales 2026 * |
3.86x | EV / Sales 2027 * | 3.5x |
| Free-Float |
86.16% | Yield 2026 * |
2.62% | Yield 2027 * | 2.79% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
London S.E.
| ABT | Delayed | |
|
Tradegate
| ABL | Real-time | |
|
Xetra
| ABL | Delayed | |
|
Boerse Muenchen
| ABL | Real-time | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Borsa Italiana
| 1ABT | End-of-day quote | |
|
CBOE
| Real-time | ||
|
CBOE
| ABT | Real-time | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Lima
| ABTUS | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Santiago S.E.
| ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | -10.05% | ||
| 1 week | +4.76% | ||
| 1 month | -3.51% | ||
| 3 months | +10.00% | ||
| 6 months | -14.73% | ||
| Current year | -23.61% |
| 1 week | 110 |  | 110 |
| 1 month | 105 | | 110 |
| Current year | 90 | | 135 |
| 1 year | 90 | | 144.1 |
| 3 years | 90 | | 144.1 |
| 5 years | 90 | | 144.1 |
| 10 years | 90 | | 144.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.06% | +4.76% | - | - | 170B | |
| +0.78% | +0.10% | -25.63% | +2.24% | 170B | |
| -0.55% | +0.45% | -11.85% | +15.37% | 111B | |
| +0.16% | +1.27% | -24.47% | +4.53% | 107B | |
| -0.03% | +0.72% | -46.94% | -10.20% | 75.95B | |
| +0.82% | +6.22% | +3.31% | +71.30% | 60.37B | |
| -0.65% | +6.59% | +11.44% | +66.40% | 53.53B | |
| +0.79% | +1.60% | -5.54% | -31.58% | 49.11B | |
| -1.30% | -2.63% | -18.94% | +14.97% | 40.6B | |
| +1.25% | -2.16% | +27.87% | +1.61% | 31.47B | |
| Average | -0.88% | +0.25% | -10.08% | +14.96% | 77.67B | |
| Weighted average by Cap. | -1.82% | -0.04% | -16.03% | +12.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.2B 44.85B 41.85B 38.01B 71.59B 4,856B 72.12B 503B 196B 2,470B 188B 184B 7,939B | 54.53B 48.72B 45.45B 41.29B 77.76B 5,275B 78.34B 546B 213B 2,683B 205B 200B 8,624B |
| Net income | 6.21B 5.55B 5.18B 4.7B 8.86B 601B 8.93B 62.23B 24.31B 306B 23.32B 22.82B 982B | 7.89B 7.05B 6.58B 5.98B 11.26B 764B 11.34B 79.07B 30.89B 388B 29.63B 28.99B 1,248B |
| Net Debt | 23.94B 21.39B 19.96B 18.13B 34.14B 2,316B 34.39B 240B 93.69B 1,178B 89.87B 87.93B 3,786B | 20.96B 18.73B 17.47B 15.87B 29.89B 2,027B 30.11B 210B 82.02B 1,031B 78.68B 76.98B 3,314B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | US$110.00 | 0.00% | 1 |
| 30/09/26 | US$110.00 | +4.76% | 3 |
| 29/09/26 | US$105.00 | -4.55% | 1 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT_KZ Stock
Select your edition
All financial news and data tailored to specific country editions
